Annual Drug Patent Expirations for CARDIZEM+LA
Cardizem La is a drug marketed by Bausch and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and two Paragraph IV challenges.
CARDIZEM LA drug price trends.
Drug patent litigation for CARDIZEM LA.
This drug has ten patent family members in eleven countries.
The generic ingredient in CARDIZEM LA is diltiazem hydrochloride. Two suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com